Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,839 companies covered, latest filing Oct 23.

  • $306M bought by 81 insiders at 62 companies
  • $364M sold by 57 insiders outside a trading plan
  • $2.6B sold by 263 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

  1. SAFXXCF Global
    EEME Energy SPV I, LLC10% owner
    119M shares at $1.19 Oct 16 +109% to stake
    $142M
  2. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    2,032,734 shares at $34.27 Oct 14–21, 6 filings +1.6% to stake 2 superinvestors bought in Q2
    $69.7M
  3. PAMPampa Energia
    Marcos Marcelo MindlinDirector
    435,000 shares at $80.78 Oct 15 +6.4% to stake
    $35.1M
  4. PEPPepsiCo
    Robert C PohladDirector
    184,646 shares at $128.28 Oct 14 +74% to stake 3 superinvestors bought in Q2
    $23.7M
  5. DOLEDole PLC
    Pale Fire Capital SE10% owner, +4 joint filers
    648,356 shares at $13.19 Oct 20–22 +6.7% to stake
    $8.6M
  6. APLDApplied Digital
    Jason Gechen ZhangPresident
    300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2
    $5.7M
  7. BORRBorr Drilling
    Tor Olav TroimDirector
    500,000 shares at $4.60 Oct 15 +1.3% to stake
    $2.3M
  8. RENTRent the Runway
    Nexus Capital Management LPDirector, +9 joint filers
    632,922 shares at $3.55 Oct 21 +15% to stake
    $2.2M
  9. RENTRent the Runway
    CHS US Investments LLC10% owner, +4 joint filers
    458,245 shares at $3.55 Oct 21 +2% to stake
    $1.6M
  10. FBKFB Financial
    Orrin H Ingram IIDirector
    29,081 shares at $52.88 Oct 20 +31% to stake
    $1.5M

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)
    $2B
  2. INSWInternational Seaways
    Famatown Finance Ltd10% owner, +2 joint filers
    1,106,190 shares at $97.01 Apr 30–Oct 8 14% of stake
    $107M
  3. SNOWSnowflake
    Frank SlootmanDirector
    300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)
    $94.9M
  4. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake
    $85.9M
  5. TRVTravelers
    Alan D SchnitzerCEO
    88,900 shares at $396.77 Oct 21 23% of stake
    $35.3M
  6. PATHUiPath
    Daniel DinesCEO
    2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)
    $33.1M
  7. UTHRUnited Therapeutics
    Martine A RothblattCEO
    57,000 shares at $553.66 Oct 15–22, 6 filings 15% of stake Planned sale (10b5-1)
    $31.6M
  8. MUMicron Technology
    Scott J DeboerPres. & Chief Tech & Prod Offr
    28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)
    $25.7M
  9. NTRANatera
    Matthew RabinowitzChair
    50,000 shares at $402.64 Oct 15 2.3% of stake Planned sale (10b5-1)
    $20.1M
  10. AFLAflac
    Japan Post Holdings Co., Ltd.10% owner
    168,611 shares at $118.29 Oct 14–15, 2 filings 0.3% of stake Planned sale (10b5-1)
    $19.9M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

CIEN insider trades

Every open-market buy and sale in CIEN, one row per filing, newest first

CIEN page
All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. Brodie Gage EVP & Chief Product & Tech
    CIENCiena
    Planned sale
    $413K 1,200 shares at $344.08 3.4% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Dino DiPerna EVP & Chief R&D Officer
    CIENCiena
    Planned sale
    $309K 890 shares at $347.04 2.4% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  3. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1M 2,952 shares at $348.02 1.3% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  4. David M Rothenstein EVP & Chief Strategy Officer
    CIENCiena
    Planned sale
    $870K 2,500 shares at $348.06 1.4% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  5. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.1M 2,952 shares at $369.66 1.3% of stake
    Traded Oct 1 Filed Oct 13
    ↗
  6. Marc D. Graff CFO
    CIENCiena
    Planned sale
    $34K 97 shares at $355.19 0.1% of stake
    Traded Oct 1 Filed Oct 6
    ↗
  7. Sheela Kosaraju EVP & Chief Legal Officer
    CIENCiena
    Planned sale
    $746K 2,101 shares at $355.19 2.4% of stake
    Traded Oct 1 Filed Oct 6
    ↗
  8. Jason Phipps EVP & Chief Customer Officer
    CIENCiena
    Planned sale
    $934K 2,629 shares at $355.19 4.4% of stake
    Traded Oct 1 Filed Oct 6
    ↗
  9. Joseph Cumello EVP & General Mgr.
    CIENCiena
    Planned sale
    $569K 1,586 shares at $358.52 3.9% of stake
    Traded Sep 25 Filed Sep 29
    ↗
  10. Bruce L. Claflin Director
    CIENCiena
    Sale
    $1M 2,857 shares at $355.91 26% of stake
    Traded Sep 24 Filed Sep 28
    ↗
  11. Thomas Michael Nevens Director
    CIENCiena
    Sale
    $1.3M 3,738 shares at $359.04 37% of stake
    Traded Sep 23 Filed Sep 25
    ↗
  12. Gary B Smith CEO
    CIENCiena
    Planned sale
    $975K 2,952 shares at $330.18 1.2% of stake
    Traded Sep 15 Filed Sep 17
    ↗
  13. David M Rothenstein EVP & Chief Strategy Officer
    CIENCiena
    Planned sale
    $826K 2,500 shares at $330.48 1.4% of stake
    Traded Sep 15 Filed Sep 17
    ↗
  14. Brodie Gage EVP & Chief Product &
    CIENCiena
    Planned sale
    $390K 1,200 shares at $324.86 3.1% of stake
    Traded Sep 15 Filed Sep 17
    ↗
  15. Dino DiPerna EVP & Chief R&D Officer
    CIENCiena
    Planned sale
    $168K 498 shares at $337.43 1.3% of stake
    Traded Sep 15–16 Filed Sep 17
    ↗
  16. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.1M 2,952 shares at $362.90 1.2% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  17. Marc D. Graff CFO
    CIENCiena
    Planned sale
    $2.2M 4,995 shares at $430.72 4.4% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  18. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $1.1M 2,500 shares at $438.10 1.4% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  19. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.3M 2,952 shares at $447.78 1.2% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  20. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $527K 1,200 shares at $439.24 3% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  21. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.1M 2,952 shares at $379.81 1.2% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  22. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.2M 2,952 shares at $421.10 1.2% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  23. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $1.1M 2,500 shares at $420.91 1.3% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  24. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $539K 1,200 shares at $449.15 2.9% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  25. Dino DiPerna SVP Global R&D
    CIENCiena
    Planned sale
    $351K 782 shares at $449.15 1.9% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  26. Sheela Kosaraju SVP and General Counsel
    CIENCiena
    Planned sale
    $938K 2,013 shares at $466.20 2.2% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  27. Marc D. Graff CFO
    CIENCiena
    Planned sale
    $59K 126 shares at $466.20 0.1% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  28. Jason Phipps SVP Global Sales and Marketing
    CIENCiena
    Planned sale
    $1.2M 2,629 shares at $466.20 4% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  29. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.4M 2,952 shares at $468.83 1.1% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  30. Joseph Cumello SVP, General Mgr. Blue Planet
    CIENCiena
    Planned sale
    $740K 1,586 shares at $466.33 3.6% of stake
    Traded Jun 26 Filed Jun 30
    ↗
  31. Marc D. Graff CFO
    CIENCiena
    Planned sale
    $57K 126 shares at $449.36 0.1% of stake
    Traded Jun 24 Filed Jun 26
    ↗
  32. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.3M 2,952 shares at $457.02 1.1% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  33. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $1.1M 2,500 shares at $457.07 1.3% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  34. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $559K 1,200 shares at $466.10 2.7% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  35. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.7M 2,952 shares at $565.92 1.1% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  36. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.7M 2,952 shares at $562.05 1.1% of stake
    Traded May 15 Filed May 19
    ↗
  37. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $1.4M 2,500 shares at $562.39 1.3% of stake
    Traded May 15 Filed May 19
    ↗
  38. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $685K 1,200 shares at $570.65 2.7% of stake
    Traded May 15 Filed May 19
    ↗
  39. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.6M 2,952 shares at $537.74 1.1% of stake
    Traded May 1 Filed May 4
    ↗
  40. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.4M 2,952 shares at $467.47 1% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  41. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $1.2M 2,500 shares at $467.65 1.3% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  42. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $566K 1,200 shares at $471.79 2.6% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  43. Dino DiPerna SVP Global R&D
    CIENCiena
    Planned sale
    $1.3M 2,829 shares at $471.79 6.2% of stake
    Traded Apr 15 Filed Apr 16
    ↗
  44. Jason Phipps SVP Global Sales and Marketing
    CIENCiena
    Planned sale
    $9M 22,014 shares at $409.80 25% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  45. Sheela Kosaraju SVP and General Counsel
    CIENCiena
    Planned sale
    $808K 2,012 shares at $401.71 2.1% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  46. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.2M 2,952 shares at $415.51 1% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  47. Joseph Cumello SVP, General Mgr. Blue Planet
    CIENCiena
    Planned sale
    $700K 1,773 shares at $394.82 3.7% of stake
    Traded Mar 27 Filed Mar 31
    ↗
  48. Brodie Gage SVP Global Products & Supply
    CIENCiena
    Planned sale
    $2M 5,000 shares at $405.00 9.7% of stake
    Traded Mar 24 Filed Mar 25
    ↗
  49. Gary B Smith CEO
    CIENCiena
    Planned sale
    $1.1M 2,952 shares at $359.53 1% of stake
    Traded Mar 16 Filed Mar 18
    ↗
  50. David M Rothenstein SVP and Chief Strategy Officer
    CIENCiena
    Planned sale
    $863K 2,500 shares at $345.00 1.3% of stake
    Traded Mar 16 Filed Mar 18
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.